2019


January: Johan Luthman appointed EVP, Research & Development

Johan is a proven and passionate leader with 28 years of experience in neuroscience and global pharmaceutical research and development. Johan will take up his new position on 1 March 2019.

January: Lundbeck commences usage of artificial intelligence in drug discovery

Once again Lundbeck strengthens its research through a partnership. Together with the US based biotech company Numerate Lundbeck will construct new drug candidates by using artificial intelligence.

Cookie Policy
You have chosen to leave www.lundbeck.com. Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on www.lundbeck.com.